Casi EstesCasi Estes
|
 |
Over time you may be removing hair less often. Vaniqa (eflornithine). It is the first and only prescription cream proven to slow the growth of unwanted facial hair (UFH) in vaniqa without prescription women. And that's wonderful news. Overall, Vaniqa statistically significantly reduced the number of patients bothered by their facial hair and by the time spent hair removal medication removing, treating, or concealing facial hair.. This slows down hair growth improving the appearance of the area where Vaniqa is used. The patients received either eflornithine detergent or a placebo cream twice vaniqa drug daily for 24 weeks. Vaniqa interferes with an enzyme found in the hair follicle of skin. This enzyme is used in the metabolism of hair and is a necessary component for its growth. Eflornithine is the first topical drug for the treatment of unwanted facial and chin hair. permanent hair removal cream The re-growth of hair was evaluated 48 hours after patients shaved before, during, and at the end of treatment. The cells surrounding the base of each hair (called vaniqa online the hair follicle) undergo rapid growth and maturation as they transform into hairs. Studies sho that improvement in unwanted facial hair was seen in approximately sixty percent of all patients after 6 months of use. Eflornithine is believed buy vaniqa to block ODC and thereby slow the growth and differentiation of the cells within the hair follicles. It does not remove the hair but rather slows its growth. Moreover, 35% of eflornithine-treated patients had a marked reduction in the rate of growth (only minimal darkening of facial skin due to re-growth of hair) compared to 9% of placebo-treated patients." Eflornithine is used to slow hair growth on the window dressing and chin in women ages 12 and older. Certain proteins called polyamines are needed for this rapid cell growth and differentiation, and the production of these polyamines depends on the activity of an enzyme, ornithine decarboxylase (ODC). By the end of 24 weeks of treatment, 70% of eflornithine-treated patients had at least some reduction in the rate of hair growth compared with 41% of placebo-treated patients. Almost 600 patients were studied who routinely had to remove facial hair at least twice weekly hair removal and had more than 5 hairs per square centimeter of skin.
|